MA46897A - Insuline dégludec utilisée dans des conditions cardiovasculaires - Google Patents

Insuline dégludec utilisée dans des conditions cardiovasculaires

Info

Publication number
MA46897A
MA46897A MA046897A MA46897A MA46897A MA 46897 A MA46897 A MA 46897A MA 046897 A MA046897 A MA 046897A MA 46897 A MA46897 A MA 46897A MA 46897 A MA46897 A MA 46897A
Authority
MA
Morocco
Prior art keywords
cardiovascular conditions
insulin degludec
degludec
insulin
cardiovascular
Prior art date
Application number
MA046897A
Other languages
English (en)
French (fr)
Inventor
Kajsa Kvist
Simon Skibsted
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of MA46897A publication Critical patent/MA46897A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA046897A 2016-11-28 2017-11-28 Insuline dégludec utilisée dans des conditions cardiovasculaires MA46897A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16200906 2016-11-28
EP17174682 2017-06-07

Publications (1)

Publication Number Publication Date
MA46897A true MA46897A (fr) 2021-04-28

Family

ID=60937677

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046897A MA46897A (fr) 2016-11-28 2017-11-28 Insuline dégludec utilisée dans des conditions cardiovasculaires

Country Status (6)

Country Link
US (2) US11278596B2 (https=)
EP (1) EP3544683A1 (https=)
JP (1) JP7193455B2 (https=)
CN (1) CN110022935A (https=)
MA (1) MA46897A (https=)
WO (1) WO2018096162A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018096162A1 (en) 2016-11-28 2018-05-31 Novo Nordisk A/S Insulin degludec in cardiovascular conditions
AR112015A1 (es) 2017-06-09 2019-09-11 Novo Nordisk As Composiciones sólidas para administración oral
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
US12343383B2 (en) 2019-07-12 2025-07-01 Novo Nordisk A/S High concentration insulin formulation
CN113773397B (zh) * 2020-06-10 2023-10-20 宁波鲲鹏生物科技有限公司 一种德谷胰岛素的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL128332A0 (en) 1996-08-30 2000-01-31 Novo Nordisk As GLP-1 derivatives
GB0309154D0 (en) * 2003-01-14 2003-05-28 Aventis Pharma Inc Use of insulin glargine to reduce or prevent cardiovascular events in patients being treated for dysglycemia
MXPA06001283A (es) 2003-08-05 2006-04-11 Novo Nordisk As Derivados de insulina novedosos.
WO2013144273A1 (en) 2012-03-28 2013-10-03 Sanofi Basal insulin therapy
JP6755175B2 (ja) * 2013-03-20 2020-09-16 ノヴォ ノルディスク アー／エス インスリン投薬レジメン
JP2016519127A (ja) 2013-04-30 2016-06-30 ノヴォ ノルディスク アー／エス 新規投与レジメン
MA46890A (fr) 2016-11-28 2021-04-28 Novo Nordisk As Insuline degludec pour l'amélioration du contrôle glycémique et la réduction des complications du diabète aigu et à long terme
WO2018096162A1 (en) 2016-11-28 2018-05-31 Novo Nordisk A/S Insulin degludec in cardiovascular conditions

Also Published As

Publication number Publication date
WO2018096162A1 (en) 2018-05-31
EP3544683A1 (en) 2019-10-02
JP7193455B2 (ja) 2022-12-20
JP2019535785A (ja) 2019-12-12
US11278596B2 (en) 2022-03-22
US20220160840A1 (en) 2022-05-26
US20190374614A1 (en) 2019-12-12
US12233114B2 (en) 2025-02-25
CN110022935A (zh) 2019-07-16

Similar Documents

Publication Publication Date Title
IL256999B (en) Diabetes management therapy advisor
ME03384B (me) Brzodjelujući pripravci inzulina
EP3305519A4 (en) METAL RESIN COMPLEX
DK3368085T3 (da) Modificerede alginater til anti-fibrotiske materialer og anvendelser
MA41188A (fr) Compositions d'insuline à action rapide
DK2963056T3 (da) Insulinanalog og anvendelse deraf
EP3227425C0 (en) LIQUID CLEANING COMPOSITIONS COMPRISING PROTEASE VARIANTS
DK3120239T3 (da) Fælles bootsekvens til styringsmodul der kan initialiseres i flere arkitekturer
DK3152607T3 (da) En antiresonant hulkernefiber
HRP20190369T1 (hr) Spojevi dihidrobenzofurana koji su korisni u liječenju dijabetesa i pretilosti
EP3314445A4 (en) COHERENT FABRIC CONNECTION FOR USE IN SEVERAL TOPOLOGIES
IL256939B (en) Rapid-acting insulin compositions
FR3024271B1 (fr) Plusieurs tailles de mots codes ecc dans un ssd
MA46897A (fr) Insuline dégludec utilisée dans des conditions cardiovasculaires
HUE055728T2 (hu) Posztbariatrikus hipoglikémia kezelése exendin(9-39)-el
DK3229828T3 (da) Formulering med fast forhold mellem insulin glargin og lixisenatid
EP3380616A4 (en) MANUFACTURE OF VIRUSES IN BIRDS
DK2959455T3 (da) Forbedringer af eller relaterende til billedbehandling
EP3371825A4 (en) COMPOSITIONS COMPRISING MATRIX AND CAPSULE MATERIALS FOR USE IN ELECTRONIC DEVICES
EP3444327C0 (en) Dishwashing tablets
EP3307306A4 (en) GENE EXPRESSION IN BACTEROIDES
DK3209677T3 (da) Varianter af gal2-transporter og anvendelser deraf
DK3324937T3 (da) Brugsfærdig bortezomib-opløsning
DK3140050T3 (da) Dosering med visning
MA43704A (fr) Liraglutide dans des états cardio-vasculaires